ANTIDIABETIC, HYPOLIPIDEMIC, AND HISTOPATHOLOGICAL ANALYSIS OF ZINGERONE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
Abstract
Objectives: This study assessed the effects of antidiabetic and hypolipidemic activity of Zingerone on STZ induced diabetic rats.
Methods: In this study 30 Wistar male rats were divided into five groups: Group 1: Normals control receiving normal saline, Group 2: Diabetic control
receiving single intraperitoneal administration of streptozotocin (STZ) (40 mg/kg body weight). Group 3: Five days after STZ administration, diabetic
rats received zingerone (10 mg/kg body weight) orally for 30 days. Group 4: Five days after STZ administration, diabetic rats received metformin
(50 mg/kg body weight) orally for 30 days and Group 5: Rats received zingerone alone (10 mg/kg body weight) orally for 30 days.
Results: Zingerone treatment significantly reduced blood glucose level, Lipid profiles of serum, liver and kidney showed higher reduction in the levels
of phospholipids (PL), triglycerides (TG) and free fatty acids (FFA) of zingerone treated diabetic rats than STZ-induced diabetic rats and Met-treated
diabetic rats. In addition, zingerone treatment of STZ-rats was found to be effective in preserving the normal histological appearance of pancreatic
islets, liver and kidney whereas the untreated diabetic rats exhibited pathological features.
Conclusions: These findings substantiated the beneficial effects of zingerone in the treatment of diabetes through exhibiting hypolipidemic effects
as well as restoring the function of several organs including the pancreas. Thus, zingerone may have the potential in managing the effects of diabetic
complications in human subjects.
Keywords: Diabetes, Streptozotocin, Ginger, Zingerone, Antidiabetic, Hypolipidaemic.
Downloads
References
American Association of Diabetes Educators. Intensive diabetes
management: Implications of the DCCT and UKPDS. Diabetes Educ
;28:735-40.
Valiathan MS. Healing plants. Curr Sci 1998;75:1122-6.
Sochar M, Baquer NZ, Mclean P. Glucose underutilizations in diabetes.
Comparative studies on the changes in the activities of enzymes of
glucose metabolism in rat kidney and liver. Mol Physiol 1985;7:51-68.
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic
complications: A new perspective on an old paradigm. Diabetes
;48(1):1-9.
Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits
lipoprotein oxidation and cytotoxicity. J Lipid Res 1989;30(12):1827-34.
Seifter S, England S. Energy metabolism. In: Arias I, Papper M,
Schacter D, Shafritz DA, editors. The Liver: Biology and Pathobiology.
New York: Raven Press; 1982. p. 219-49.
Baquer NZ. Glucose over utilization and underutilization in diabetes
and effects of antidiabetic compounds. Ann Real Acad Farm
;64:147-80.
Warier PK. Eugenia jambolana Linn. In: Warier PK, Nambiar VP,
Ramankutty C, editors. Indian Medicinal Plants. Madras: Orient
Longman; 1995. p. 48-51.
Srivastava Y, Bhat HV, Verma Y, Venkaidh K. Antidiabetic and
adaptogenic properties of Momordica charantia extract: An
experimental and clinical evaluation. Phytother Res 1993;7:285-9.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian
herbs and herbal drugs used for the treatment of diabetes. J Clin
Biochem Nutr 2007;40(3):163-73.
Mandlik RV, Desai SK, Naik SR, Sharma G, Kohli RK. Antidiabetic
activity of a polyherbal formulation (DRF/AY/5001). Indian J Exp Biol
;46(8):599-606.
Park KK, Chun KS, Lee JM, Lee SS, Surh YJ. Inhibitory effects of
-gingerol, a major pungent principle of ginger, on phorbol esterinduced
inflammation,
epidermal ornithine
decarboxylase
activity
and
skin
tumor promotion in ICR mice. Cancer Lett 1998;129(2):139-44.
Kumar L, Chhibber S, Harjai K. Zingerone suppresses liver
inflammation induced by antibiotic mediated endotoxemia through
down regulating hepatic mRNA expression of inflammatory markers
in Pseudomonas aeruginosa peritonitis mouse model. PLoS One
;9(9):e106536.
Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R,
Ali M. Anti-diabetic and hypolipidaemic properties of ginger
(Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr
;96(4):660-6.
Grzanna R, Lindmark L, Frondoza CG. Ginger – An herbal
medicinal product with broad anti-inflammatory actions. J Med Food
;8(2):125-32.
Chen H, Soroka DN, Hu Y, Chen X, Sang S. Characterization of thiolconjugated
metabolites
of ginger components shogaol in mouse and
human
urine
and
modulation
of
the glutathione
levels
in
cancer
cells
by
-shogaol.
Mol Nutr Food Res 2013;57:447-58.
Daily JW, Yang M, Kim DS, Park S. Efficacy of ginger for treating
Type 2 diabetes: A systematic review and meta-analysis of randomized
clinical trials. J Ethnic Foods 2015;2:36-43.
Shin SG, Kim JY, Chung HY, Jeong JC. Zingerone as an antioxidant
against peroxynitrite. J Agric Food Chem 2005;53(19):7617-22.
Chung SW, Kim MK, Chung JH, Kim DH, Choi JS, Anton S, et al.
Peroxisome proliferator-activated receptor activation by a short-term
feeding of zinger one in aged rats. J Med Food 2009;12(2):345-50.
Chen JC, Huang LJ, Wu SL, Kuo SC, Ho TY, Hsiang CY. Ginger
and its bioactive component inhibit enterotoxigenic Escherichia coli
heat-labile enterotoxin-induced diarrhea in mice. J Agric Food Chem
;55(21):8390-7.
Kumar L, Chhibber S, Harjai K. Zingerone inhibit biofilm formation
and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas
aeruginosa PAO1. Fitoterapia 2013;90:73-8.
Chang YP, Liu CH, Wu CC, Chiang CM, Lian JL, Hsieh SL. Dietary
administration of zingerone to enhance growth, non-specific immune
response, and resistance to Vibrio alginolyticus in Pacific white
shrimp (Litopenaeus vannamei) juveniles. Fish Shellfish Immunol
;32(2):284-90.
Vinothkumar R, Vinothkumar R, Sudha M, Nalini N. Chemopreventive
effect of zingerone against colon carcinogenesis induced by
,2-dimethylhydrazine in rats. Eur J Cancer Prev 2014;23(5):361-71.
Cheta D. Animal models of Type 1 (insulin-dependent) diabetes
mellitus. J Pediatr Endocrinol Metab 1998;11(1):11-9.
Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation
and purification of total lipids from animal tissues. J Biol Chem
;226 Suppl 1:497-509.
Parkeh AC, Jung DH. Cholesterol determination with ferric chloride
uranium acetate and sulphuric acid-ferrous suphate reagents. Anal
Chem 1970;42:1423-7.
Foster LB, Dunn RT. Stable reagents for determination of serum
triglycerides by a colorimetric Hantzsch condensation method. Clin
Chem 1973;19(3):338-40.
Zilversmit DB, Davis AK. Microdetermination of plasma phospholipids
by trichloroacetic acid precipitation. J Lab Clin Med 1950;35(1):155-60.
Hron WT, Menahan LA. A sensitive method for the determination of
free fatty acids in plasma. J Lipid Res 1981;22(2):377-81.
Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination
of serum cholesterol. J Lab Clin Med 1953;41(3):486-92.
Foster LB and Dunn RT. Stable reagents for determination of serum
triglycerides by a colorimeter Hantzsch condensation method. Clin
Chem. 1973;19:338-40.
Fiske CH, Subbarow Y. The colorimetric determination of phosphorous.
J Biol Chem 1925;66:375.
Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation
of lipoproteins from human serum by precipitation with polyanions.
J Lipid Res 1970;11(6):583-95.
Friedewald WT, Levy RI, Frederickson DS. Estimation of concentration
of low density lipoprotein cholesterol in plasma without the use of
preparative ultracentrifuge. Clin Chem 1972;19:449-52.
Bierman EL, Amaral JA, Balknap BH. Hyperlipemia and diabetes
mellitus. Diabetes 1975;25:509-15.
Shanmugasundaram ER, Gopinath KL, Radha Shanmugasundaram K,
Rajendran VM. Possible regeneration of the islets of Langerhans in
streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts.
J Ethnopharmacol 1990;30(3):265-79.
Shepherd J. Does statin monotherapy address the multiple lipid
abnormalities in Type 2 diabetes? Atheroscler Suppl 2005;6(3):15-9.
Ananthan R, Latha M, Ramkumar KM, Pari L, Baskar C, Narmatha
Asian J Pharm Clin Res, Vol 9, Issue 3, 2016, 220-224
Jothi et al.
Bai V. Effect of Gymnema montanum leaves on serum and tissue lipids
in alloxan diabetic rats. Exp Diabesity Res 2003;4(3):183-9.
Shirwaikar A, Shirwaikar A, Rajendran K, Punitha IS. In vitro
antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine.
Biol Pharm Bull 2006;29(9):1906-10.
Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP.
Antidiabetic and antihyperlipidemic effects of neem seed kernel
powder on alloxan diabetic rabbits. Indian J Pharmacol 1997;29:162-7.
Pushparaj P, Tan CH, Tan BK. Effects of Averrhoa bilimbi leaf
extract on blood glucose and lipids in streptozotocin-diabetic rats.
J Ethnopharmacol 2000;72(1-2):69-76.
Milagro FI, MartÃnez JA. Effects of the oral administration of a beta3adrenergic
agonist on lipid metabolism in
alloxan-diabetic rats.
J
Pharm
Pharmacol
;52(7):851-6.
Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics.
ed. New York: MacMillan; 1985. p. 1490-510.
Mascolo N, Jain R, Jain SC, Capasso F. Ethnopharmacologic
th
investigation of ginger (Zingiber officinale). J Ethnopharmacol
;27(1-2):129-40.
Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber
officinale Rosc.) and fenugreek (Tringonella foenumgraecum L.) on
blood lipids, blood sugar and platelet aggregation in patients with
coronary artery disease. Prostaglandins Leukot Essent Fatty Acids
;56:379-84.
Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of
Zingiber officinale in streptozotocin-induced Type 1 diabetic rats.
J Pharm Pharmacol 2004;56(1):101-5.
Govindarajan VS. Ginger - chemistry, technology, and quality
evaluation: Part 1. Crit Rev Food Sci Nutr 1982;17(1):1-96.
Govindarajan VS. Ginger-chemistry, technology, and quality
evaluation: Part 2. Crit Rev Food Sci Nutr 1982;17(3):189-258.
Mustafa T, Srivastava KC, Jensen KB. Drug development report (9):
Pharmacology of ginger, Zingiber officinale. J Drug Dev 1994;6:25-39.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.